MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:POLBF)

0.0919 UNCHANGED
Last Price Updated: 10:55 AM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0919
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0919
Today's Range 0.0919 - 0.0919
52wk Range 0.0425 - 0.1154
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Change of Registered Address
Via ACCESSWIRE

Performance

YTD
+39.0%
+39.0%
1 Month
-3.6%
-3.6%
3 Month
+39.9%
+39.9%
6 Month
+39.0%
+39.0%
1 Year
+116.2%
+116.2%

More News

Read More
News headline image
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
Via ACCESSWIRE
News headline image
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Via News Direct
Topics Intellectual Property
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Via TheNewswire.com
Topics Intellectual Property
News headline image
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Appointment of Joint Broker
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 US Patent Update
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Director Share Purchase
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 Data Presented at ASH
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Directorate Change
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
Via ACCESSWIRE
News headline image
Former Amryt Pharma Leadership Team join Poolbeg
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Update
Via ACCESSWIRE
News headline image
Poolbeg Pharma PLC Announces POLB 001 Oncology Programme Update Meeting
Via ACCESSWIRE
Poolbeg Pharma unveils new collaboration agreement
Via News Direct
Poolbeg Pharma unveils new collaboration agreement
Via TheNewswire.com

Frequently Asked Questions

Is POLBF publicly traded?
Yes, POLBF is publicly traded.
What exchange does POLBF trade on?
POLBF trades on the OTC Traded
What is the ticker symbol for POLBF?
The ticker symbol for POLBF is POLBF on the OTC Traded
What is the current price of POLBF?
The current price of POLBF is 0.0919
When was POLBF last traded?
The last trade of POLBF was at 06/12/26 10:55 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story